National Alliance names Jenny Goins interim CEO after former leader’s arrest; details emerge on charges, firing timeline, and impact on healthcare policy circles.
|Articles|February 23, 2022
MHE Talks: Wes Gilson of Siemens Healthineers Addresses How Crucial Improving Access to MRI is to Advancing Health Equity
Author(s)Briana Contreras
Welcome back to another episode of the returned MHE Talks: Improving Patient Access podcast. In this episode Briana Contreras, editor of Managed Healthcare Executive, spoke with Wes Gilson, senior director MR of Business Development at Siemens Healthineers. In the conversation, the two discussed why improving access to magnetic resonance imaging (MRI) is crucial to advancing health equity. Gilson addressed the barriers many face when accessing MRI services and its solutions from tackling the barriers specific to areas affected, alternative technologies, developing new innovations in MRI tech and more.
Advertisement
Advertisement
Related to this article
Only 19% use AI predictive models in cancer care despite strong belief in impact; 2026 Oncology Care Index highlights reimbursement, training, funding barriers.
Hispanic HIV incidence rose 16.8% in antisanctuary counties after the 2018 public charge announcement, relative to baseline counties, a new study found.
A review of randomized clinical trials, nonrandomized trials and case reports suggests that the inflammatory bowel disease risk from treatment with IL-17 inhibitors is low.
From a 95% remission rate in Japan to $81.6 billion in U.S. savings since 2015 — a data-driven look at where biosimilars stand today, and where the gaps remain.
AI pathology tool measures lung cancer treatment response after neoadjuvant chemoimmunotherapy with 91% accuracy, speeding NSCLC care while needing review for complete response.
A review of 57 studies found music eases pain through positive emotion, control and moving in time with the beat, according to recent research out of Drexel University.
UC San Diego researchers found that early-onset metabolic dysfunction-associated steatotic liver disease cirrhosis was linked to higher genetic risk and Type 2 diabetes prevalence.
Advertisement
Advertisement